EXTERNAL RESEARCH FUNDING

Current Support

CIHR - April 2023 – March 2028
“Epigenetic regulation of the adenovirus genome”
Program: Project Grant

CIHR - October 2022 – September 2026
“Extracellular vesicles as a biomarker and therapeutic for Spinal Muscular Atrophy”
Program: Project Grant
Co-PI: Rashmi Kothary (OHRI), Jodi Warman Chardon (TOH), Otis Vacratsis (University of Windsor)

University of Ottawa - Faculty of Medicine
"B3 for NMD Translational Research Biobank Proposal"

NSERC - April 2019 – March 2024
“DYRK2 co-regulates apoptosis and innate immunity in response to genotoxic stress”
Program: Discovery Grant

Previous Support (last 10 years only)

CIHR - April 2021 - March 2022
"Extracellular vesicles as a biomarker and therapeutic for Spinal Muscular Atrophy"
Program: Project Grant

CIHR - October 2015 - September 2021
“Epigenetic regulation of the adenovirus genome”
Program: Operating Grant
Note: one-year extension due to COVID

CIHR - April 2021 – March 2022
“Extracellular vesicles as a biomarker and therapeutic for Spinal Muscular Atrophy”
Program: Priority Announcement: Musculoskeletal Health and Arthritis
Co-PI: Rashmi Kothary (OHRI), Jodi Warman Chardon (TOH), Otis Vacratsis (University of Windsor)

CureSMA - March 2018 – February 2020
“Serum-derived exosomes as a biomarker for Spinal Muscular Atrophy”
Program: Operating Grant

CIHR - October 2014 - September 2019
“Development of novel therapeutics for the treatment of the genetic disorder Spinal Muscular Atrophy”
Program: Operating Grant; Co-PI - Rashmi Kothary (OHRI)

NSERC - April 2014 – March 2019
“DYRK2 co-regulates apoptosis and innate immunity in response to genotoxic stress”
Program: Discovery Grant

Cancer Research Society - September 2014 - August 2016
“Cancer therapy using a combination of oncolytic adenovirus vector and Smac mimetics”
Program: Operating Grant

NIH Subaward - August 2013 – July 2014
“Cocaine hydrolase gene therapy for cocaine abuse (DPI)”
Principle Applicant: Stephen Brimijoin, Mayo Clinic Rochester MN
Program: 2010 NIDA Translational Avant-Garde Award for Medication Development for Diseases of Addiction (DP1) 5DP1DA03134004

CIHR - April 2009 – March 2014
“Structure/function studies of adenovirus in the infected cell”
Program: Operating Grant

NSERC - April 2012 – March 2013
“Structure/function studies of adenovirus capsid protein IX”
Program: Discovery Grant - Individual

CIHR - January 2010 – March 2013
“Regulation of innate immunity during development”
Program: Operating Grant

Canada Foundation for Innovation (CFI) - November 2011 – October 2012
“Spinal Muscular Atrophy – Pathogenesis and Novel Therapeutics”
Program – Infrastructure Operating Fund, Co-PI – Dr. Rashmi Kothary (OHRI)

CIHR - October 2010 – September 2012
“Development of a novel therapy for treatment of Spinal Muscular Atrophy”
Program – Catalyst Grant/Inventions, Co-PI – Dr. Rashmi Kothary (OHRI)